Integrated Filing — IndAS



General information about company

Scrip Code 543389
NSE Symbol SIGACHI
MSEI Symbol NOTLISTED
ISIN INE0D0K01022
Name of company SIGACHI INDUSTRIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 13-08-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 07-08-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 13-08-2026   12:00:00
End date and time of board meeting 13-08-2026   16:00:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 12,127.38 12,127.38
Other income 100.29 100.29
Total income 12,227.67 12,227.67
2 Expenses
(a) Cost of materials consumed 5,472.90 5,472.90
(b) Purchases of stock-in-trade 595.72 595.72
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (304.29) (304.29)
(d) Employee benefit expense 2,844.78 2,844.78
(e) Finance costs 301.31 301.31
(f) Depreciation, depletion and amortisation expense 441.28 441.28
(f) Other Expenses
1 Manufacturing Expenses 415.86 415.86
2 Rent 24.37 24.37
3 Insurance 35.93 35.93
4 Selling Expenses 159.78 159.78
5 Travelling and Conveyance 164.11 164.11
6 Professional and Consultancy fees 424.38 424.38
7 Carriage Outward 192.92 192.92
8 CSR 3.00 3.00
9 Communication Expenses 15.59 15.59
10 Other Expenses 431.06 431.06
Total other expenses 1,867.00 1,867.00
Total expenses 11,218.70 11,218.70
3 Total profit before exceptional items and tax 1,008.97 1,008.97
4 Exceptional items 0.00 0.00
5 Total profit before tax 1,008.97 1,008.97
6 Tax expense
7 Current tax 256.56 256.56
8 Deferred tax (62.06) (62.06)
9 Total tax expenses 194.50 194.50
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 814.47 814.47
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 814.47 814.47
17 Other comprehensive income net of taxes 190.34 190.34
18 Total Comprehensive Income for the period 1,004.81 1,004.81
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 675.94 675.94
Total profit or loss, attributable to non-controlling interests 138.53 138.53
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 865.70 865.70
Total comprehensive income for the period attributable to owners of parent non-controlling interests 139.11 139.11
21 Details of equity share capital
Paid-up equity share capital 3,821.17 3,821.17
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.18 0.18
Diluted earnings (loss) per share from continuing operations 0.18 0.18
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.18 0.18
Diluted earnings (loss) per share from continuing and discontinued operations 0.18 0.18
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above unaudited standalone financial results for the quarter ended 30.06.2026 , have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on 13.08.2026 2. The consolidated financial results of the Company have been prepared in accordance with the Indian Accounting Standards (Ind-AS) as prescribed under section 133 of the Companies Act, 2013 read with Companies (Indian Accounting Standards) Rules, 2015, as amended,and in terms of regulation 33 of the SEBI ( Listing Obiligations and Disclosure Requirements) 2015, as ammended.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026 01-04-2026
Date of end of reporting period 30-06-2026 30-06-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Pharmaceuticals 10,821.40 10,821.40
2 Operational and Management 1,305.97 1,305.97
Total Segment Revenue 12,127.37 12,127.37
Less: Inter segment revenue 0.00 0.00
Revenue from operations 12,127.37 12,127.37
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Pharmaceuticals 1,081.67 1,081.67
2 Operational and Management 228.61 228.61
Total Profit before tax 1,310.28 1,310.28
i. Finance cost 301.31 301.31
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax 1,008.97 1,008.97
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Pharmaceuticals 0.00 0.00
2 Operational and Management 0.00 0.00
Total Segment Asset 0.00 0.00
Un-allocable Assets 0.00 0.00
Net Segment Asset 0.00 0.00
4 Segment Liabilities
Segment Liabilities
1 Pharmaceuticals 0.00 0.00
2 Operational and Management 0.00 0.00
Total Segment Liabilities 0.00 0.00
Un-allocable Liabilities 0.00 0.00
Net Segment Liabilities 0.00 0.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit and loss 12.69 12.69
Total Amount of items that will not be reclassified to profit and loss 12.69
2 Income tax relating to items that will not be reclassified to profit or loss 4.19 4.19
3 Amount of items that will be reclassified to profit and loss
1 Items that will be reclassified to profit and loss 181.84 181.84
Total Amount of items that will be reclassified to profit and loss 181.84
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 190.34 190.34





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Yelamanchi & Associates Yes 31-10-2028